Supplementary Table S4 from Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors

2026 Open access

Read full text
Authors: Kimberly J. Perez, Nora Horick, Joanna Baginksa, Anita Giobbie‐Hurder, Ilana Gomez Diaz, Allison N. Nau, Ian D. Dryg, Kathleen Lindahl Pfaff, Scott J. Rodig, Frank Stephen Hodi, Mark S. Redston, Alexandra Bird
+7 more Marta M. Holovatska, Thomas Abrams, Anuj Patel, Douglas Adam Rubinson, Benjamin L. Schlechter, Matthew H. Kulke, Jennifer Ang Chan
DOI: 10.1158/1078-0432.31248809
Cited by: 0

Fields of Study & Subjects

Neuroendocrine Tumor Research Advances Neuroblastoma Research and Treatments Cancer Immunotherapy and Biomarkers

Publication details

Publication date
4 February 2026